Titre : | Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France (2018) |
Auteurs : | L. BRIAND MADRID ; S. MOREL ; K. NDIAYE ; S. MEZAACHE ; D. ROJAS CASTRO ; M. MORA ; F. OLIVET ; V. LAPORTE ; C. PROTOPOPESCU ; P. CARRIERI ; P. ROUX |
Type de document : | Article : Périodique |
Dans : | Drug and Alcohol Dependence (Vol.190, September 2018) |
Article en page(s) : | 121-127 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus géographique FRANCEThésaurus mots-clés USAGER ; OPIOIDES ; MORPHINE ; METHADONE ; LIBIDO ; SEXUALITE ; INJECTION ; ENQUETE ; ETUDE TRANSVERSALE ; HEROINE ; BUPRENORPHINE |
Mots-clés: | PrebupIV |
Résumé : |
Background: Regular consumption of opioids exposes individuals to several side effects. One of these is a loss of libido, which has a negative impact on quality of life. We used a cross-sectional community-based survey of people who inject opioids to study factors associated with loss of libido, and more particularly the impact of the type of opioid injected.
Methods: This secondary study was conducted throughout France in 2015 and involved 514 people who inject opioids. Self-reported sociodemographic characteristics, drug consumption, injection-related data and loss of libido were collected using a brief questionnaire administered either through face-to-face interviews or online. Two different models were used to identify factors associated with loss of libido: simple logistic regression and a two-step Heckman model. Results: Forty-three percent of the participants reported a loss of libido. The first model showed that filling in the questionnaire online (OR[95%CI] = 2.55[1.64;3.96]; p Conclusion: Our findings showed that full-opioid agonists could have a negative impact on libido when injected regularly. Libido can improve quality of life and should be routinely discussed through counseling in prevention services with people who inject drugs. Highlights: This study investigates the impact of the type of opioids injected on libido. Type of questioning (online or face-to-face) shows libido is still a taboo subject. The type of opioid used plays a significant role in how serious the libido loss is. Buprenorphine appears to be the opioid with the weakest effect. |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
Affiliation : | Aix Marseille Université, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Faculté de médecine, Marseille, France |
Accueil